GMP: FDA plans significant increase of GMP Inspections in China
19.12.2013
The US FDA has elaborated concrete plans to increase the number of inspections in China. These plans were developed as a consequence of the Heparin crisis. Already in 2008, the US FDA opened offices in China to increase the number of GMP Inspections.
SciencePharma
